RICHARD PRINS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Amphastar Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2015-04-08	Richard Prins has served as a member of our board of directors since February 2002. Since 2008, Mr. Prins has been a private investor and involved in various charitable organizations. Mr. Prins also volunteers as acting head of U.S. Operations for Advancing Native Missions and on the boards of directors of India Globalization Capital and Hilbert Technology. Mr. Prins was the Director of Investment Banking for Ferris, Baker Watts, Inc., or FBW, from 1996 until June 2008 when FBW was acquired by Royal Bank of Canada and served as a consultant to Royal Bank of Canada Capital Markets through December 2008. Prior to FBW, Mr. Prins was a Managing Director from July 1988 to April 1996 at Crestar Bank (now SunTrust Bank) in charge of mergers and acquisitions. Mr. Prins began his career in 1983 as the Assistant to the Chairman of the leverage buyout company, Tuscarora Corp., where he held various positions until July 1988. Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2016-04-22	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2017-04-21	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2018-04-18	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2019-04-18	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2020-04-15	Richard Prins has been a private investor and involved in various charitable organizations. Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2021-04-14	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2022-04-14	Mr. Prins was the Director of Investment Banking for FBW, from 1996 until June 2008 when FBW was acquired by Royal Bank of Canada. Prior to FBW, Mr. Prins was a Managing Director from July 1988 to April 1996 at Crestar Bank (now Truist Bank) in charge of mergers and acquisitions. Mr. Prins began his career in 1983 as the Assistant to the Chairman of the leverage buyout company, Tuscarora Corp., where he held various positions until July 1988. Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2023-04-14	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.
2024-04-12	Mr. Prins received a B.A. in liberal arts from Colgate University and an M.B.A. from Oral Roberts University.

IGC Pharma, Inc.

Filing Date	Source Excerpt
2008-02-08	Richard Prins... holds a B.A. degree from Colgate University (1980), and an M.B.A. from Oral Roberts University (1983).
2008-06-25	Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2011-08-01	Mr. Prins has more than 26 years of experience in private equity investing and investment banking. He holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2011-12-09	Mr. Richard Prins has served as our Director since May 2007. ... Mr. Prins has excellent knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of Boards, has extensive experience in finance, accounting, and internal controls over financial reporting.
2013-09-04	Mr. Prins has more than 27 years of experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW). FBW was the lead underwriter for our IPO. FBW was sold to Royal Bank of Canada (RBC) in 2008. Mr. Prins served in a consulting role to RBC until January 2009.
2014-08-04	Mr. Richard Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2015-07-24	Richard Prins has been our Chairman and Audit Committee Chairman since 2012, and has served as a Director since May 2007. Prins has more than 27 years of experience in private equity investing and investment banking. He holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2017-10-10	Mr. Prins has extensive experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW).
2018-07-06	Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, has extensive experience in finance, accounting, and internal controls over financial reporting.
2019-12-13	Mr. Prins has extensive experience in private equity investing and investment banking. ... Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2020-12-08	Mr. Richard Prins has been our Chairman and Audit Committee Chairman since 2012 and has served as a Director since May 2007. On November 25 and December 1, 2020, Mr. Prins was also appointed by the Board as the Chairman of the Company’s Disclosure and Compensation Committees, respectively. Mr. Prins has extensive experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW). Mr. Prins served in a consulting role to RBC until January 2009. Mr. Prins currently serves on several boards, volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals, Inc. From March 2010 until 2016, he was on the board of Hilbert Technologies. Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, has extensive experience in finance, accounting, and internal controls over financial reporting. His knowledge of the pharmaceutical industry and experience with U.S. capital markets make him well qualified to serve as a director of our Company.
2021-09-15	Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, has extensive experience in finance, accounting, and internal controls over financial reporting.
2022-07-25	Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has extensive experience in finance, accounting, and internal controls over financial reporting.
2023-07-26	Mr. Prins has extensive experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated (FBW). Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University.
2024-07-08	Richard Prins has been our Chairman, Audit Committee, and Compensation Committee Chairman since 2012 and has served as an Independent Director since May 2007. Mr. Prins has extensive experience in private equity investing and investment banking. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated ("FBW"). Mr. Prins served in a consulting role for RBC until January 2009. Since February 2003, he has been on the board of Amphastar Pharmaceuticals, Inc. Mr. Prins holds a B.A. degree from Colgate University and an M.B.A. from Oral Roberts University. Mr. Prins has substantial knowledge and experience with U.S. capital markets, has served on and chaired audit and compensation committees of boards, and has extensive experience in finance, accounting, and internal controls over financial reporting.

Data sourced from SEC filings. Last updated: 2026-03-05